Skip to main content
SpringerLink
Log in

Bivalent HPV vaccination cost effective in Afghanistan

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Anwari P, et al. Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan. Vaccine : 20 Dec 2019. Available from: URL: http://doi.org/10.1016/j.vaccine.2019.12.013

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bivalent HPV vaccination cost effective in Afghanistan. PharmacoEcon Outcomes News 844, 8 (2020). https://doi.org/10.1007/s40274-020-6471-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6471-8

Search

Navigation